Even among the ZNF family that has been understudied in general, ZNF92 stands out as a particularly unexplored transcription factor that has never been studied in cancer since its cloning in 1993, and mentioned only once in association with the cholesterol-lowering drug atorvastatin43,46. This evidence concerns the gene ZNF92 and cancer.